Nosebleed News and Research

RSS
New evidence-based clinical practice guideline for nosebleed published

New evidence-based clinical practice guideline for nosebleed published

Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects

Clinical trial: Oral drug improves exercise capacity in teens with congenital heart defects

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Study shows ticagrelor is equally safe and effective as clopidogrel after heart attack

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Studies examine effectiveness of nasal sprays in reducing frequency, duration of HHT-related epistaxis

Study: Cancer drug may help reduce bleeding in HHT patients

Study: Cancer drug may help reduce bleeding in HHT patients

Identifying infant and toddler injuries that require emergency medical care

Identifying infant and toddler injuries that require emergency medical care

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Researchers develop therapeutic algorithm to study outcomes in epistaxis management

Analysts predict continued Medicare cost growth slowdown

Analysts predict continued Medicare cost growth slowdown

First Edition: May 31, 2013

First Edition: May 31, 2013

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Sunovion launches ZETONNA Nasal Aerosol for allergic rhinitis

Bacon for nosebleeds: Case report

Bacon for nosebleeds: Case report

Creighton researcher to study role of adult stem cells in repairing damaged coronary arteries

Creighton researcher to study role of adult stem cells in repairing damaged coronary arteries

Continuous positive airway pressure machine more effective for sleep apnea patients

Continuous positive airway pressure machine more effective for sleep apnea patients

Extreme heat and rain lead to higher mold count in the Midwest

Extreme heat and rain lead to higher mold count in the Midwest

Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

Updated Phase 1 study results of FOLOTYN in patients with refractory CTCL presented at ASH 2010

Acceleron announces ACE-031 Phase 1b study results

Acceleron announces ACE-031 Phase 1b study results

Rebirth of the cursed drug Thalidomide

Rebirth of the cursed drug Thalidomide

AVASTIN receives Health Canada approval for patients with GBM

AVASTIN receives Health Canada approval for patients with GBM

Cancer drug could be effective for treating recurrent nose bleeds

Cancer drug could be effective for treating recurrent nose bleeds

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research

Anticoagulants used to prevent clots in placental blood vessels ineffective, reveals research